FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP 1s BioSpace The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC